My insight again shown lacking. Didn't see this coming with over $19M in the bank!. $3.5M placement at a discount to some prominent WA investors. All part of the profile raising with the new board members?

The Company welcomes prominent investors Mr Chris Ellison, Mr Rod Jones, Mr Michael Malone, the McCusker Family and the Merchant Biotech Fund, which significantly strengthens the Company’s share register

• With existing cash of $19.6 million, pending R+D Tax rebate of circa $3.0 million and the Strategic Placement of $3.5 million, the Company is very well funded for its global market expansion strategy and well beyond the pivotal US product registration for Remplir™ expected in Q1 CY24